Assessment of bronchodilator responsiveness to salbutamol or ipratropium using different criteria in treatment-naïve patients with asthma and COPD

References

• Global Startegy for Asthma Management and Prevention. 2019. Available from: https://www.ginaasthma.org.
   Google Scholar
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2019 report. 2019. Available from: https://www.copdgold.org
   Google Scholar
• Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365(13):1184–10. doi: 10.1056/NEJMoa1105482
   PubMed Web of Science ®Google Scholar
• Marin JM, Ciudad M, Moya V, et al. Airflow reversibility and long-term outcomes in patients with COPD without comorbidities. Respir med. 2014;108(8):1180–1188. doi: 10.1016/j.rmed.2014.05.006
   PubMed Web of Science ®Google Scholar
• Ejiofor S, Turner AM. Pharmacotherapies for COPD. Clin Med Insights: Circ Respir Pulm Med. 2013;7:17–34. doi: 10.4137/CCRPM.S7211
   PubMedGoogle Scholar
• van Noord JA, Smeets JJ, Maesen FP. A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction. Respir Med. 1998;92(12):1346–1351. doi: 10.1016/S0954-6111(98)90140-8
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Bronchodilators: basic pharmacology. In: Calverley PMA P NB, editors Chronic obstructive pulmonary disease. London: Chapman and Hall; 1995: pp. 391–417.
   Google Scholar
• Brusasco V. Reducing cholinergic constriction: the major reversible mechanism in COPD. Eur Respir Rev. 2006;15(99):32–36. doi: 10.1183/09059180.00009902
   Google Scholar
• Lipson DA. Tiotropium bromide. Int J Chron Obstruct Pulmon Dis. 2006;1(2):107–114. doi: 10.2147/copd.2006.1.2.107
   PubMedGoogle Scholar
• Schlueter DP Ipratropium bromide in asthma. A review of the literature. Am J Med. 1986;81(5):55–60. doi: 10.1016/0002-9343(86)90463-8
   PubMedGoogle Scholar
• Calverley PM, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58(8):659–664. doi: 10.1136/thorax.58.8.659
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi: 10.1183/09031936.05.00035205
   PubMed Web of Science ®Google Scholar
• Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499. doi: 10.1183/13993003.01499-2021
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi: 10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi: 10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Team RC. R: a language and environment for statistical computing. Vienna, Austria:R Foundation for Statistical Computing; 2020. Available from: https://www.R-project.org/
   Google Scholar
• Montes de Oca M, Perez-Padilla R, Talamo C, et al. Acute bronchodilator responsiveness in subjects with and without airflow obstruction in five Latin American cities: the PLATINO study. Pulm Pharm Ther. 2010;23(1):29–35. doi: 10.1016/j.pupt.2009.09.005
   PubMed Web of Science ®Google Scholar
• Tommola M, Won HK, Ilmarinen P, et al. Relationship between age and bronchodilator response at diagnosis in adult-onset asthma. Respir Res. 2020;21(1):179. doi: 10.1186/s12931-020-01441-w
   PubMed Web of Science ®Google Scholar
• Albert P, Agusti A, Edwards L, et al. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease. Thorax. 2012;67(8):701–708. doi: 10.1136/thoraxjnl-2011-201458
   PubMed Web of Science ®Google Scholar
• Chaiwong W, Deesomchok A, Pothirat C, et al. Impact of the new European respiratory (Ers)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines 2021 on the interpretation of bronchodilator responsiveness in subjects with airway obstruction. Respir Med. 2023;220:107460. doi: 10.1016/j.rmed.2023.107460
   PubMed Web of Science ®Google Scholar
• Li Y, Lin J, Wang Z, et al. Bronchodilator responsiveness defined by the 2005 and 2021 ERS/ATS criteria in patients with asthma as well as chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2022;17:2623–2633. doi: 10.2147/COPD.S385733
   PubMed Web of Science ®Google Scholar
• Palmer LJ, Celedon JC, Chapman HA, et al. Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum Mol Genet. 2003;12(10):1199–1210. doi: 10.1093/hmg/ddg125
   PubMed Web of Science ®Google Scholar
• Lehmann S, Bakke PS, Eide GE, et al. Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community. Respir Med. 2007;101(6):1183–1190. doi: 10.1016/j.rmed.2006.11.007
   PubMed Web of Science ®Google Scholar
• Nichol G, Nix A, Barnes PJ, et al. Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs. Thorax. 1990;45(9):694–698. doi: 10.1136/thx.45.9.694
   PubMed Web of Science ®Google Scholar
• Ali Z, Dirks CG, Ulrik CS. Long-term mortality among adults with asthma: a 25-year follow-up of 1,075 outpatients with asthma. Chest. 2013;143(6):1649–1655. doi: 10.1378/chest.12-2289
   PubMed Web of Science ®Google Scholar
• Feng M, Zhang X, Wu WW, et al. Clinical and inflammatory features of exacerbation-prone asthma: a cross-sectional study using multidimensional assessment. Respiration. 2020;99(12):1109–1121. doi: 10.1159/000510793
   PubMed Web of Science ®Google Scholar